| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |